Posted on August 31, 2009
Filed Under Acne | Leave a Comment
SEATTLE — The treatment of acne in adolescents should be tailored to the type and severity of lesions and the adolescent's age, according to Dr. Annette Wagner. Fully 80% of teenagers develop acne, noted Dr. Wagner, a pediatric dermatologist at Northwestern University in Chicago. “But the age of onset is really young now that puberty is starting earlier,” she commented. “I see comedones on many 8-year-olds in my clinic.” (Source: Skin and Allergy News)
Posted on August 31, 2009
Filed Under Acne | Leave a Comment
Conclusion: Cetuximab combined wthe either radiotherapy or chemotherapy are good options for suitable patients with head and neck cancer.
PMID: 19728918 [PubMed - in process] (Source: Ai Zheng)
Posted on August 31, 2009
Filed Under Acne | Leave a Comment
Authors: Goldgar C, Keahey DJ, Houchins J
Rosacea is a common chronic, and sometimes progressive, dermatosis. It is characterized, alone or in combination, by central facial erythema,symmetric flushing, stinging sensation, inflammatory lesions (papules and pustules), telangiectasias, and phymatous changes (tissue hyperplasia and nodules). Rosacea can occur in adults of any ethnicity,and adversely affects patients' quality of life. The condition can be effectively controlled with therapy tailored to the specific subtype of rosacea that is affecting the patient. Topical metronidazole, sulfacetamide/sulfur, and azelaic acid are generally effective for patients with mild rosacea. For moderate papulopustular rosacea, combination therapy with oral tetracyclines and topical agents is the firs...
MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
Posted on August 31, 2009
Filed Under Acne | Leave a Comment
Washington ?An advertisement for Aczone (Allergan), a gel used to treat mild-to-moderate acne,
"grossly overstates" the drug?s effectiveness, the Food and Drug Administration (FDA) stated in a
letter released Aug. 21. (Source: Modern Medicine)
Posted on August 31, 2009
Filed Under Acne | Leave a Comment
One of the primary factors contributing to the development of acne vulgaris is excess sebum. Sebaceous glands and sebum excretion are regulated, at least in part, by androgen hormones. Acne treatments that block this androgen effect include spironolactone and combination oral contraceptives (COC). Three COC are now FDA approved to treat moderate acne. Dermatologists must become experts at prescribing these hormonal contraceptives. Likewise, it is vital to be aware of contraindications to hormonal contraceptive therapy. Proper patient selection relies on an appropriate medical history and an assessment of blood pressure. A pelvic exam and/or Papanicolaou smear are not required prior to initiating therapy with a COC. It is important to counsel patients about potential adverse effects of COC ...
keep looking »